No Picture
Boston Cambridge Biotech Trending News

STAT+: With its Alzheimer’s drug in turmoil, Biogen eyes a list of potential acquisitions

Biogen, desperate to reverse the turmoil surrounding its controversial Alzheimer’s treatment Aduhelm, has a shopping list of potential acquisitions, STAT has learned. And the company’s risk-averse board, which has repeatedly rejected potential deals, could be […]

No Picture

Covid-19 roundup: AstraZeneca touts booster as effective against Omicron; Africa CDC reportedly in talks to buy Paxlovid

Though it still hasn’t received FDA authorization for its Covid-19 vaccine, AstraZeneca is charting a course for booster shots. On Thursday, the British-Swedish pharma company revealed new information for its Vaxzevria shot, saying a booster […]